Hypersensitivity, Immediate D006969

Diseases [C] » Immune System Diseases [C20] » Hypersensitivity » Hypersensitivity, Immediate

Description

Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.   MeSH

Hierarchy View

Subtype Terms (8)

Anaphylaxis
15 drugs (10 approved, 5 experimental)

Asthma, Aspirin-Induced
5 drugs (4 approved, 1 experimental)

Conjunctivitis, Allergic
78 drugs (39 approved, 39 experimental)

Dermatitis, Atopic
346 drugs (103 approved, 243 experimental)

Eosinophilic Esophagitis
36 drugs (25 approved, 11 experimental)

Food Hypersensitivity
46 drugs (14 approved, 32 experimental)

Respiratory Hypersensitivity
3 approved drugs

Urticaria
52 drugs (35 approved, 17 experimental)


Phase 4 Indicated Drugs (1)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 4 Indications (3)

Organization Involved with Phase 3 Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.